Supplemental oxygen costs and equipment utilization in a low-income population with ILD or COPD

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Rationale</h4> Supplemental oxygen is often prescribed to patients with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD). The specific costs of oxygen therapy in these diseases have not been fully described in patients living in the United States. <h4>Objectives</h4> Estimate Medicaid/Medicare costs for supplemental oxygen, characterize differences in oxygen...

Topics

Open a Topic to create a Post that cites this publication.

• Disease Progression
• Idiopathic Pulmonary Fibrosis
• Lung Diseases, Interstitial
• Muscle Physiology and Disorders
• Neurogenetic and Muscular Disorders Research
• Patient Acceptance of Health Care
• Phenotype

Identifiers and source

Literature Corpus work

75606ac8-a2e6-574e-969d-a5b01244f483

DOI

10.1101/2024.11.23.24317811